Neurones S.A. (EPA: NRO)
France
· Delayed Price · Currency is EUR
45.40
+0.40 (0.89%)
Nov 22, 2024, 5:35 PM CET
Neurones Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 774.91 | 741.18 | 665.38 | 579.88 | 524.49 | 510.07 | Upgrade
|
Revenue Growth (YoY) | 9.62% | 11.39% | 14.74% | 10.56% | 2.83% | 4.08% | Upgrade
|
Cost of Revenue | 408.41 | 394.42 | 356.26 | 323.3 | 296.19 | 293.54 | Upgrade
|
Gross Profit | 366.5 | 346.76 | 309.12 | 256.58 | 228.3 | 216.53 | Upgrade
|
Selling, General & Admin | 268.61 | 248.58 | 215 | 174.75 | 154.44 | 146.99 | Upgrade
|
Other Operating Expenses | 7.62 | 7.58 | 6.49 | 5.38 | 6.94 | 5.43 | Upgrade
|
Operating Expenses | 292.94 | 272.06 | 236.89 | 194.93 | 176.41 | 167.47 | Upgrade
|
Operating Income | 73.57 | 74.69 | 72.22 | 61.64 | 51.89 | 49.07 | Upgrade
|
Interest Expense | -1.52 | -1.43 | -1.7 | -0.97 | -1.02 | -1.35 | Upgrade
|
Interest & Investment Income | 8.39 | 5.92 | 1.66 | 1.15 | 1.02 | 1.19 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | -0.02 | - | -0.21 | 0.24 | Upgrade
|
EBT Excluding Unusual Items | 80.44 | 79.18 | 72.16 | 61.83 | 51.68 | 49.15 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.89 | 0.43 | 0.03 | 0 | 1.91 | 0.04 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.13 | 0.83 | 0.06 | -0.3 | -0.09 | 4.53 | Upgrade
|
Other Unusual Items | -0.24 | 0.33 | 0.61 | 0.23 | 0.06 | 0.1 | Upgrade
|
Pretax Income | 81.21 | 80.77 | 72.86 | 61.76 | 53.56 | 53.81 | Upgrade
|
Income Tax Expense | 23.39 | 22.18 | 21.09 | 18.82 | 18.58 | 18.65 | Upgrade
|
Earnings From Continuing Operations | 57.82 | 58.58 | 51.77 | 42.94 | 34.99 | 35.16 | Upgrade
|
Minority Interest in Earnings | -9.33 | -9.17 | -7.53 | -5.23 | -4.07 | -4.36 | Upgrade
|
Net Income | 48.49 | 49.41 | 44.24 | 37.71 | 30.92 | 30.8 | Upgrade
|
Net Income to Common | 48.49 | 49.41 | 44.24 | 37.71 | 30.92 | 30.8 | Upgrade
|
Net Income Growth | 1.84% | 11.68% | 17.34% | 21.95% | 0.39% | 18.64% | Upgrade
|
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade
|
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade
|
Shares Change (YoY) | 0.11% | 0.10% | 0.18% | -0.13% | -0.07% | 0.09% | Upgrade
|
EPS (Basic) | 2.00 | 2.04 | 1.83 | 1.56 | 1.28 | 1.27 | Upgrade
|
EPS (Diluted) | 1.99 | 2.03 | 1.82 | 1.55 | 1.27 | 1.27 | Upgrade
|
EPS Growth | 1.53% | 11.54% | 17.42% | 22.05% | 0.13% | 18.57% | Upgrade
|
Free Cash Flow | 42.92 | 54.09 | 44.36 | 57.92 | 60.1 | 53.43 | Upgrade
|
Free Cash Flow Per Share | 1.76 | 2.22 | 1.83 | 2.39 | 2.48 | 2.20 | Upgrade
|
Dividend Per Share | 1.200 | 1.200 | 1.100 | 1.000 | - | 0.200 | Upgrade
|
Dividend Growth | 9.09% | 9.09% | 10.00% | - | - | 233.33% | Upgrade
|
Gross Margin | 47.30% | 46.78% | 46.46% | 44.25% | 43.53% | 42.45% | Upgrade
|
Operating Margin | 9.49% | 10.08% | 10.85% | 10.63% | 9.89% | 9.62% | Upgrade
|
Profit Margin | 6.26% | 6.67% | 6.65% | 6.50% | 5.89% | 6.04% | Upgrade
|
Free Cash Flow Margin | 5.54% | 7.30% | 6.67% | 9.99% | 11.46% | 10.48% | Upgrade
|
EBITDA | 82.2 | 82.72 | 79.57 | 69.42 | 59.79 | 56.98 | Upgrade
|
EBITDA Margin | 10.61% | 11.16% | 11.96% | 11.97% | 11.40% | 11.17% | Upgrade
|
D&A For EBITDA | 8.63 | 8.02 | 7.35 | 7.78 | 7.91 | 7.92 | Upgrade
|
EBIT | 73.57 | 74.69 | 72.22 | 61.64 | 51.89 | 49.07 | Upgrade
|
EBIT Margin | 9.49% | 10.08% | 10.85% | 10.63% | 9.89% | 9.62% | Upgrade
|
Effective Tax Rate | 28.80% | 27.47% | 28.95% | 30.47% | 34.68% | 34.67% | Upgrade
|
Revenue as Reported | 774.91 | 741.18 | 665.38 | 579.88 | 524.49 | 510.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.